Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus
Overview
Authors
Affiliations
Mitochondrial respiration is regulated in CD8(+) T cells during the transition from naive to effector and memory cells, but mechanisms controlling this process have not been defined. Here we show that MCJ (methylation-controlled J protein) acted as an endogenous break for mitochondrial respiration in CD8(+) T cells by interfering with the formation of electron transport chain respiratory supercomplexes. Metabolic profiling revealed enhanced mitochondrial metabolism in MCJ-deficient CD8(+) T cells. Increased oxidative phosphorylation and subcellular ATP accumulation caused by MCJ deficiency selectively increased the secretion, but not expression, of interferon-γ. MCJ also adapted effector CD8(+) T cell metabolism during the contraction phase. Consequently, memory CD8(+) T cells lacking MCJ provided superior protection against influenza virus infection. Thus, MCJ offers a mechanism for fine-tuning CD8(+) T cell mitochondrial metabolism as an alternative to modulating mitochondrial mass, an energetically expensive process. MCJ could be a therapeutic target to enhance CD8(+) T cell responses.
Wu M, Valenca-Pereira F, Cendali F, Giddings E, Pham-Danis C, Yarnell M Nat Commun. 2024; 15(1):4444.
PMID: 38789421 PMC: 11126743. DOI: 10.1038/s41467-024-48653-y.
Oligonucleotide therapies for nonalcoholic steatohepatitis.
Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J Mol Ther Nucleic Acids. 2024; 35(2):102184.
PMID: 38665220 PMC: 11044058. DOI: 10.1016/j.omtn.2024.102184.
Barbier-Torres L, Chhimwal J, Kim S, Ramani K, Robinson A, Yang H Int J Biol Sci. 2024; 20(4):1218-1237.
PMID: 38385082 PMC: 10878152. DOI: 10.7150/ijbs.90104.
Unveiling the mechanisms and challenges of cancer drug resistance.
Khan S, Fatima K, Aisha S, Malik F Cell Commun Signal. 2024; 22(1):109.
PMID: 38347575 PMC: 10860306. DOI: 10.1186/s12964-023-01302-1.
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
Santamans A, Cicuendez B, Mora A, Villalba-Orero M, Rajlic S, Crespo M Sci Adv. 2024; 10(3):eadk6524.
PMID: 38241373 PMC: 10798563. DOI: 10.1126/sciadv.adk6524.